Firm
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Laura Achával, founder of Achával IP in Argentina, shares how an evolving vision led her to launch her own practice
Sponsored
Sponsored
-
Sponsored by MaiwaldGisela Grabow of Maiwald considers the potential changes to the EU’s general pharmaceutical legislation under a recent proposal, and the main questions raised for stakeholders -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law reports on South Korea’s bid to lead the way on autonomous vehicles with a streamlined patent process.
-
Sponsored by Tilleke & GibbinsLoc Xuan Le of Tilleke & Gibbins reviews two thought-provoking Vietnamese IP cases, with potentially far-reaching implications for the country’s IP enforcement system.
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA Technology and IP Attorneys underline the importance of trademark protection in a booming nutraceuticals market in India and explain what steps brand owners should take
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos says that clarification from the EPO Enlarged Board of Appeal may be necessary after a series of rulings concerning the format of oral proceedings in appeals
-
Sponsored by Remfry & SagarAn increasing number of AI-based patent applications and an efficiency drive at the Indian IP office are among the trends identified by Bisman Kaur of Remfry & Sagar in India’s dynamic IP space
